Biography

Nisha is a strategic, creative and fearless advocate who provides comprehensive advice on Canadian and multi-jurisdictional litigation. She has represented clients before the Ontario Superior Court and Federal Court of Canada in matters related to all aspects of intellectual property. Nisha’s practice focuses primarily on patent litigation in various industry sectors, including pharmaceuticals, telecommunications, and oil and gas. She also advises clients on intellectual property and litigation strategy, and pharmaceutical clients on regulatory matters with Health Canada.

A scientist-turned-litigator, Nisha completed a PhD in molecular biology, genetics and cancer at McMaster University prior to obtaining her law degree from the University of Toronto. Nisha is active in the local legal community. She frequently volunteers to speak on panels related to advocacy or intellectual property, judge moots, teach trial advocacy, and to mentor young lawyers.

*Practicing as Nisha Anand Professional Corporation

Education

University of Toronto, Faculty of Law
  • J.D. - 2008
McMaster University, Medical Sciences
  • Ph.D. - 2006
Acadia University
  • B.Sc. - 1999

Representative Cases

  • Weatherford Canada Ltd. et al v. Corlac Industries (1998) Ltd. et al T-1236-01 (2008-2010) Co-counsel to the defendants in a patent infringement action and the appellants in the subsequent appeal  
  • Apotex Inc. v. Eli Lilly Canada Inc. T-1321-97 (2013) Co-counsel to Eli Lilly in a section 8 damages action pursuant to the Patented Medicines (Notice of Compliance) Regulations
  • Apotex Inc. v. Hoffman-La Roche Limited T-1165-09 (2013-2015) Co-counsel to Hoffman La-Roche in a section 8 damages action pursuant to the Patented Medicines (Notice of Compliance) Regulations
  • Apotex Inc. v. Pfizer Inc. et al T-1736-10 (2014-2016) Co-counsel to Pfizer in a section 8 damages action pursuant to the Patented Medicines (Notice of Compliance) Regulations
  • Gilead Sciences, Inc. et al. v Apotex Inc. et al. 2016 FC 856 Co-counsel to Gilead in a proceeding under the Patented Medicines (Notice of Compliance) regulations
  • Gilead Sciences, Inc. v Teva Canada Limited T-1888-15 (2015) Co-counsel to Gilead in a proceeding under the Patented Medicines (Notice of Compliance) regulations and a patent infringement action.
  • Safe Gaming System Inc. v. Atlantic Lottery Corporation et al. 2018 FC 871 (2017) Co-counsel to Safe Gaming System in a patent infringement action
  • Paladin Labs Inc. v. The Minister of Health and Taro Pharmaceuticals Inc. T-157-16 (2015-2016) Co-counsel to Paladin Labs in an application for judicial review of a decision by the Minister of Health
  • Apotex Inc. v. Merck Sharp and Dohme Corp. CV-1200-454108-0000 (2015-2017) Co-counsel to Merck in an action for damages under the Statute of Monopolies and Trademarks Act
  • Wi-LAN Inc. v. LG Electronics, Inc. et al T-1349-17 (2017-2020) Co-counsel to Wi-LAN in a patent infringement action involving issues related to Standards Essential Patents (SEPs) and FRAND  
  • Wi-LAN Inc. v. Bell Mobility Inc., Rogers Communications Canada Inc. and Telus Communications Company T-303-16, T-304-16 and T-301-16 (2018-2020) Co-counsel to Wi-LAN in a patent infringement action involving issues related to Standards Essential Patents (SEPs) and FRAND  
  • Viiv Healthcare Company et al. v. Gilead Sciences, Inc. 2020 FC 486 T-226-18, 2021 FCA 122 Co-counsel to Gilead in a patent infringement action where non-infringement was decided by summary trial.  
  • Pliteq Inc. v. Ecore International Inc. et al T-365-20 (2020-2021) Co-counsel to Pliteq Inc. in a patent infringement action  
  • Ecore International Inc. v. Pliteq Inc. T-1479-19 (2020-2021) Co-counsel to Pliteq in a patent infringement action
  • Pliteq Inc. v. Ecore International, Inc. T-875-16 (2020-2021) Co-counsel to Pliteq in an action for trademark infringement and making false and misleading representations under the Trademarks and Competition Acts
  • Pliteq Inc. v. Wilrep Ltd. T-554-16 (2020-2021) Co-counsel to Pliteq in an action for trademark infringement and making false and misleading representations under the Trademarks and Competition Acts
  • Pliteq Inc. v. Sof Surfaces Inc. CV-18-00611575-0000 (2021-2022) Co-counsel to Pliteq in an action for trademark infringement and making false and misleading representations under the Trademarks and Competition Acts
  • Wi-LAN Inc. v. Apple Inc. et al T-893-21 (2021-2022) Co-counsel to Wi-LAN in a patent infringement action involving issues related to Standards Essential Patents (SEPs) and FRAND  
  • The Incorporated d.b.a. The Tragically Hip v. Trillium Beverage Inc. d.b.a Mill Street Brewery T-236-21 (2021-2022) Co-counsel to The Tragically Hip in a trademark and copyright infringement action related to the song “At the Hundredth Meridian”
  • Medexus Pharmaceuticals Inc. et al v. Accord Healthcare Inc. and Intas Pharmaceuticals Ltd. T-1007-20 (2022-2023) Co-counsel for the defendants in a patent infringement action
  • Steelhead LNG (ASLNG) Ltd. et al v. ARC Resources et al T-1488-20 (2022-2023) Co-counsel to Steelhead in a patent infringement action
  • The Haudenosaunee Development Institute v. Garlow Media d/b/a/ Two Row Times et al CV-23-00699171-0000 (2023- ) Co-counsel to The Haudenosaunee Development Institute in an action for libel and defamation

Representative Cases

  • Weatherford Canada Ltd. et al v. Corlac Industries (1998) Ltd. et al T-1236-01 (2008-2010) Co-counsel to the defendants in a patent infringement action and the appellants in the subsequent appeal  
  • Apotex Inc. v. Eli Lilly Canada Inc. T-1321-97 (2013) Co-counsel to Eli Lilly in a section 8 damages action pursuant to the Patented Medicines (Notice of Compliance) Regulations
  • Apotex Inc. v. Hoffman-La Roche Limited T-1165-09 (2013-2015) Co-counsel to Hoffman La-Roche in a section 8 damages action pursuant to the Patented Medicines (Notice of Compliance) Regulations
  • Apotex Inc. v. Pfizer Inc. et al T-1736-10 (2014-2016) Co-counsel to Pfizer in a section 8 damages action pursuant to the Patented Medicines (Notice of Compliance) Regulations
  • Gilead Sciences, Inc. et al. v Apotex Inc. et al. 2016 FC 856 Co-counsel to Gilead in a proceeding under the Patented Medicines (Notice of Compliance) regulations
  • Gilead Sciences, Inc. v Teva Canada Limited T-1888-15 (2015) Co-counsel to Gilead in a proceeding under the Patented Medicines (Notice of Compliance) regulations and a patent infringement action.
  • Safe Gaming System Inc. v. Atlantic Lottery Corporation et al. 2018 FC 871 (2017) Co-counsel to Safe Gaming System in a patent infringement action
  • Paladin Labs Inc. v. The Minister of Health and Taro Pharmaceuticals Inc. T-157-16 (2015-2016) Co-counsel to Paladin Labs in an application for judicial review of a decision by the Minister of Health
  • Apotex Inc. v. Merck Sharp and Dohme Corp. CV-1200-454108-0000 (2015-2017) Co-counsel to Merck in an action for damages under the Statute of Monopolies and Trademarks Act
  • Wi-LAN Inc. v. LG Electronics, Inc. et al T-1349-17 (2017-2020) Co-counsel to Wi-LAN in a patent infringement action involving issues related to Standards Essential Patents (SEPs) and FRAND  
  • Wi-LAN Inc. v. Bell Mobility Inc., Rogers Communications Canada Inc. and Telus Communications Company T-303-16, T-304-16 and T-301-16 (2018-2020) Co-counsel to Wi-LAN in a patent infringement action involving issues related to Standards Essential Patents (SEPs) and FRAND  
  • Viiv Healthcare Company et al. v. Gilead Sciences, Inc. 2020 FC 486 T-226-18, 2021 FCA 122 Co-counsel to Gilead in a patent infringement action where non-infringement was decided by summary trial.  
  • Pliteq Inc. v. Ecore International Inc. et al T-365-20 (2020-2021) Co-counsel to Pliteq Inc. in a patent infringement action  
  • Ecore International Inc. v. Pliteq Inc. T-1479-19 (2020-2021) Co-counsel to Pliteq in a patent infringement action
  • Pliteq Inc. v. Ecore International, Inc. T-875-16 (2020-2021) Co-counsel to Pliteq in an action for trademark infringement and making false and misleading representations under the Trademarks and Competition Acts
  • Pliteq Inc. v. Wilrep Ltd. T-554-16 (2020-2021) Co-counsel to Pliteq in an action for trademark infringement and making false and misleading representations under the Trademarks and Competition Acts
  • Pliteq Inc. v. Sof Surfaces Inc. CV-18-00611575-0000 (2021-2022) Co-counsel to Pliteq in an action for trademark infringement and making false and misleading representations under the Trademarks and Competition Acts
  • Wi-LAN Inc. v. Apple Inc. et al T-893-21 (2021-2022) Co-counsel to Wi-LAN in a patent infringement action involving issues related to Standards Essential Patents (SEPs) and FRAND  
  • The Incorporated d.b.a. The Tragically Hip v. Trillium Beverage Inc. d.b.a Mill Street Brewery T-236-21 (2021-2022) Co-counsel to The Tragically Hip in a trademark and copyright infringement action related to the song “At the Hundredth Meridian”
  • Medexus Pharmaceuticals Inc. et al v. Accord Healthcare Inc. and Intas Pharmaceuticals Ltd. T-1007-20 (2022-2023) Co-counsel for the defendants in a patent infringement action
  • Steelhead LNG (ASLNG) Ltd. et al v. ARC Resources et al T-1488-20 (2022-2023) Co-counsel to Steelhead in a patent infringement action
  • The Haudenosaunee Development Institute v. Garlow Media d/b/a/ Two Row Times et al CV-23-00699171-0000 (2023- ) Co-counsel to The Haudenosaunee Development Institute in an action for libel and defamation

Recognition

  • Best Lawyers in Canada: Intellectual Property Law
  • Canadian Lexpert Directory: Intellectual Property – Consistently Recommended  
  • Canadian Lexpert Directory: Litigation-Intellectual Property – Repeatedly Recommended
  • Lexpert Special Edition: Technology & Health – Leading Lawyer
  • IAM 1000 – Recommended Individual
  • IP Stars – Patent Star
  • Who’s Who Legal Canada: Life Sciences – Recommended  
  • Whos’ Who Legal Canada: Patents – Recommended  
  • Canadian Institute for Health Research Doctoral Research Award 2003-2005
  • Ontario Graduate Studentship 2003-2004

Published Works

  • "Canada: SEPs and FRAND – Litigation, Policy and LatestDevelopments." IAM Media, 8 Dec. 2023, www.iam-media.com/hub/sepfrand-hub/2023/article/canada-seps-and-frand-litigation-policy-and-latest-developments.
  • “Patented Medicines Notice of Compliance Regulations” Chapter in Blanchard (ed), Life Sciences Law in Canada, 2nd ed (Toronto: Carswell, looseleaf)
  • Kristin Wall and Nisha Anand: “Recent Trends in Canadian Biologics Patent Litigation” FDLI Update, 2014
  • Heller, D. & Anand N. “Functional Pharma Claim Flawed, Finds Federal Court of Canada”, APLF IP Law Bugle, 2010
  • Thornton S, Anand N, Purcell D, Lee J. (2003) Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis. J Mol Med. 81(9): 536-48, 2003
  • Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM. (2002) Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet. Jul;31(3):301-5.

Qualifications

  • Bar Admission (Ontario), 2009
  • Trademark Agent, 2010